Filing Flows › Ardent Health (ARDT) › Guidance & outlook
Ardent Health (ARDT) guidance and outlook
Ardent Health (ARDT) raised some and lowered other parts of its guidance on Nov 4, 2026: EBITDA +1.5% for FY2026; EBITDA $500M–$535M for FY2026; Revenue $6.4B–$6.7B for FY2026; Net income $110M for FY2026. Ardent Health's 10-Q filed Nov 5, 2026 makes 17 forward-looking statements.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| EBITDA | FY2026 | +1.5% | raised |
| EBITDA | FY2026 | $500M–$535M | raised |
| Revenue | FY2026 | $6.4B–$6.7B | raised |
| Net income | FY2026 | $110M | lowered |
| EBITDA | FY2026 | $485M | reaffirmed |
| EPS | FY2026 | $0.78 | lowered |
From the earnings release filed Nov 4, 2026 (8-K on EDGAR).
Forward-looking statements, 10-Q filed Nov 5, 2026
- business prospects and strategy, anticipated financial position, liquidity and capital needs, the industry in which we operate
- Our historical results are not necessarily indicative of the results that may be expected for any period in the
- on our hospitals that have physician owners; (5) the ability to achieve operating and financial targets, develop and execute
- impact demand for medical services and may reduce our revenues and ability to grow profitability; (10) continued industry
- conduct a significant portion of our operations, including anticipated synergies of past acquisitions and the risk that
- particular relevance to us, the OBBBA may reduce the federal government's overall Medicaid expenditures and tighten
- The provisions of the OBBBA are not expected to have a material impact on our effective tax
- We expect the expiration of the enhanced subsidies to adversely impact results in 2026, and the OBBBA reforms
- to ACA marketplace exchange-based plans to adversely impact results in future periods, partially offset by our ongoing
- we will continue to monitor state‑level program development and funding opportunities as implementation progresses.
- we can receive for our services will reduce our total revenue and our operating margins.
- items and unusual or non-recurring items that we do not expect to continue in the future and certain other adjustments we
Ardent Health's latest quarter
Ardent Health, Q3 2026: revenue $1.6B (+3% year over year), operating margin 5.0%, net earnings $44.5M, operating cash flow $122M. The chart follows the revenue to costs, profit and cash.
Questions
Did Ardent Health raise or lower its guidance?
Ardent Health (ARDT) raised some and lowered other parts of its guidance on Nov 4, 2026: EBITDA +1.5% for FY2026; EBITDA $500M–$535M for FY2026; Revenue $6.4B–$6.7B for FY2026; Net income $110M for FY2026.
What does Ardent Health expect?
business prospects and strategy, anticipated financial position, liquidity and capital needs, the industry in which we operate Our historical results are not necessarily indicative of the results that may be expected for any period in the on our hospitals that have physician owners; (5) the ability to achieve operating and financial targets, develop and execute
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.